Cáncer Renal segunda línea - page 31

Hammers HJ, et al. J Clin Oncol 2015; 33 (suppl): Abstract 4516

CheckMate 016: Nivolumab + Ipilimumab

phase I

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,21,22,23,24,25,26,27,28,29,30 32,33,34,35